The Relationship of Mitral Annular Calcification and Aortic Valve Sclerosis to Endothelial Dysfunction

Mohammed N Elganainy1, Mohamad H Farrag1, Ehab N Selim1

  • 1Cardiovascular Medicine, National Heart Institute, Cairo, EGY.

Cureus
|June 6, 2024
PubMed

Insights

Mitral annular calcification (MAC) and aortic valve sclerosis (AVS) are linked to increased carotid intima-media thickness (CIMT), indicating a connection to systemic atherosclerosis. Further research is needed to understand the cardiovascular implications of these valvular calcifications.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Echocardiography

Background:

  • Calcific aortic valve disease (CAVD) and mitral annular calcification (MAC) are associated with cardiovascular diseases and systemic vascular pathologies.
  • The relationship between MAC, aortic valve sclerosis (AVS), and markers of vascular dysfunction like carotid intima-media thickness (CIMT) and endothelial function is not well understood.

Purpose of the Study:

  • To investigate the associations between MAC, AVS, and vascular dysfunction markers, specifically CIMT and endothelial function.
  • To explore the link between valvular calcifications and subclinical atherosclerosis.

Main Methods:

  • Prospective observational study of 200 patients undergoing echocardiography.
  • Stratification into isolated MAC, isolated AVS, combined MAC and AVS, and control groups.
  • Assessment of CIMT and endothelial function using carotid duplex ultrasonography and reactive hyperemia testing.

Main Results:

  • Patients with isolated AVS, isolated MAC, and combined MAC and AVS showed increased CIMT compared to controls.
  • The combined MAC and AVS group had significantly higher CIMT than controls (p=0.031).
  • AVS was associated with a higher likelihood of increased CIMT (p=0.008); endothelial dysfunction was not significantly different across groups.

Conclusions:

  • MAC and AVS are associated with increased CIMT, suggesting a role in systemic atherosclerotic processes.
  • While endothelial dysfunction was not significantly elevated, findings highlight the need for further cardiovascular research in CAVD and MAC.
  • The study underscores the connection between valvular calcification and subclinical vascular changes.
Abstract

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...